CSII in type 2 diabetes

Hélène Hanaire

in Insulin Pump Therapy and Continuous Glucose Monitoring

Published on behalf of Oxford University Press

ISBN: 9780199568604
Published online May 2011 | e-ISBN: 9780199607440 | DOI:

Series: Oxford Diabetes Library

CSII in type 2 diabetes

More Like This

Show all results sharing this subject:

  • Endocrinology and Diabetes


Show Summary Details


• Continuous subcutaneous insulin infusion (CSII) seems more effective than multiple daily insulin injections (MDI) in obese insulin-resistant type 2 diabetic patients in poor metabolic control • Education of the patient to the adjustment of the treatment is mandatory • CSII is feasible and acceptable in the long term in type 2 diabetic patients, and improves quality of life and treatment satisfaction • More scientific evaluation is needed to determine more precisely the indications for CSII in type 2 diabetes

Chapter.  3979 words.  Illustrated.

Subjects: Endocrinology and Diabetes

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.